TABLE 3.
Sociodemographic and clinical variables of the patient and control group.
| Variables |
Patients n = 33 |
Controls n = 33 |
All n = 66 |
| f (%) | f (%) | (f, %) | |
| Sociodemographic | |||
| Ageyears old M(±) | 44.3 ± 9.0 | 44.1 ± 12.7 | 43.7 ± 10.9 |
| Gender | |||
| Male | 24(72.7) | 25(75.8) | 49(74.2) |
| Female | 9(27.3) | 8(24.2) | 17(25.8) |
| Schooling(years) | |||
| Basic (<6) | 17(51.5) | 16(48.5) | 33(50.0) |
| Medium (7 and 12) | 9(27.3) | 10(30.3) | 19(28.8) |
| High (>12) | 7(21.2) | 7(21.2) | 14(21.1) |
| Clinical | |||
| Years of evolution of the disease | |||
| Short | 16(48.5) | – | – |
| Long | 17(51.5) | – | – |
| Clinical treatment device | |||
| In-hospital | 18(54.5) | – | – |
| Outpatient | 15(45.5) | – | – |
| Pharmacological treatment | |||
| Typical antipsychotics | 4(12.1) | – | – |
| Atypical antipsychotics | 18(54.5) | – | – |
| Typical and atypical antipsychotics | 3(9.1) | – | – |
| Other medications | 8(24.2) | – | – |